Centennial Partners
Biotechnology
| Partner | About | Website | Address |
|---|---|---|---|
| Aspa Therapeutics | Aspa Therapeutics is working to develop a safe and effective gene therapy for patients with Canavan disease, a rare condition caused by an inherited mutation of the ASPA gene. | Partner Site | Partners II |
| Adrenas Therapeutics Inc. | Adrenas Therapeutics is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Partner Site | Partners II |
| Benanova Inc. | Benanova Inc. has developed a cost-efficient, environmentally benign particle system (EbNPs) made of natural materials, which can leverage the functional properties of bioactive agents. This innovative, patent-pending technology can facilitate the development of highly efficient, application-customized and environmentally benign replacements for silver nanoparticle antimicrobials. |
Partner Site | Partners II |